 Kami Schneider
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Counseling | 6 | 2024 | 72 | 1.940 |
Why?
| | Genetic Testing | 5 | 2024 | 428 | 1.420 |
Why?
| | Genetic Predisposition to Disease | 10 | 2025 | 2269 | 0.990 |
Why?
| | Neoplastic Syndromes, Hereditary | 6 | 2025 | 38 | 0.920 |
Why?
| | Neurofibromatosis 1 | 2 | 2021 | 45 | 0.830 |
Why?
| | Anemia, Aplastic | 1 | 2021 | 36 | 0.740 |
Why?
| | Aniridia | 1 | 2020 | 4 | 0.720 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 19 | 0.720 |
Why?
| | Ribonuclease III | 4 | 2025 | 37 | 0.710 |
Why?
| | Codon, Nonsense | 1 | 2020 | 39 | 0.700 |
Why?
| | Eye Proteins | 1 | 2020 | 88 | 0.690 |
Why?
| | DEAD-box RNA Helicases | 4 | 2025 | 65 | 0.690 |
Why?
| | Early Detection of Cancer | 5 | 2025 | 369 | 0.680 |
Why?
| | Myelodysplastic Syndromes | 1 | 2021 | 129 | 0.660 |
Why?
| | Kidney Neoplasms | 2 | 2021 | 350 | 0.660 |
Why?
| | Wilms Tumor | 1 | 2020 | 77 | 0.650 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2021 | 592 | 0.490 |
Why?
| | Neoplasms | 3 | 2024 | 2463 | 0.460 |
Why?
| | Biomarkers, Tumor | 1 | 2021 | 1179 | 0.440 |
Why?
| | Phenotype | 1 | 2021 | 3051 | 0.390 |
Why?
| | Hamartoma Syndrome, Multiple | 2 | 2025 | 14 | 0.380 |
Why?
| | Counselors | 2 | 2024 | 12 | 0.370 |
Why?
| | Mutation | 3 | 2025 | 3696 | 0.370 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2024 | 72 | 0.350 |
Why?
| | Central Nervous System Neoplasms | 2 | 2023 | 149 | 0.310 |
Why?
| | Fellowships and Scholarships | 1 | 2011 | 272 | 0.290 |
Why?
| | Child | 14 | 2025 | 20805 | 0.290 |
Why?
| | DNA Mismatch Repair | 3 | 2024 | 47 | 0.290 |
Why?
| | Societies, Medical | 1 | 2011 | 744 | 0.280 |
Why?
| | von Hippel-Lindau Disease | 1 | 2025 | 12 | 0.240 |
Why?
| | Leiomyomatosis | 1 | 2025 | 4 | 0.240 |
Why?
| | DNA Repair-Deficiency Disorders | 1 | 2024 | 2 | 0.230 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 751 | 0.230 |
Why?
| | Tuberous Sclerosis | 1 | 2025 | 49 | 0.230 |
Why?
| | Rare Diseases | 1 | 2025 | 100 | 0.220 |
Why?
| | Students | 1 | 2009 | 570 | 0.220 |
Why?
| | Prognosis | 3 | 2021 | 3780 | 0.220 |
Why?
| | Skin Neoplasms | 2 | 2025 | 820 | 0.220 |
Why?
| | PTEN Phosphohydrolase | 1 | 2025 | 158 | 0.210 |
Why?
| | Germ-Line Mutation | 2 | 2021 | 138 | 0.210 |
Why?
| | Brain Neoplasms | 2 | 2022 | 1172 | 0.200 |
Why?
| | Peutz-Jeghers Syndrome | 2 | 2024 | 9 | 0.200 |
Why?
| | Adenomatous Polyposis Coli | 2 | 2024 | 33 | 0.200 |
Why?
| | DNA Repair Enzymes | 1 | 2021 | 21 | 0.180 |
Why?
| | Pulmonary Blastoma | 1 | 2021 | 8 | 0.180 |
Why?
| | Humans | 23 | 2025 | 128495 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2021 | 11 | 0.180 |
Why?
| | Child, Preschool | 5 | 2021 | 10487 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1490 | 0.170 |
Why?
| | Adolescent | 8 | 2025 | 20304 | 0.150 |
Why?
| | Codes of Ethics | 1 | 2017 | 17 | 0.140 |
Why?
| | Ethics, Professional | 1 | 2017 | 15 | 0.140 |
Why?
| | Retinoblastoma Binding Proteins | 1 | 2017 | 5 | 0.140 |
Why?
| | Optic Nerve Glioma | 1 | 2017 | 1 | 0.140 |
Why?
| | Neurofibromatoses | 1 | 2017 | 6 | 0.140 |
Why?
| | Pinealoma | 1 | 2017 | 11 | 0.140 |
Why?
| | Neurilemmoma | 1 | 2017 | 21 | 0.140 |
Why?
| | Retinoblastoma | 1 | 2017 | 31 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2023 | 3339 | 0.140 |
Why?
| | Neuroblastoma | 1 | 2017 | 153 | 0.130 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 153 | 0.130 |
Why?
| | Genetic Association Studies | 1 | 2018 | 361 | 0.130 |
Why?
| | Infant | 4 | 2023 | 9001 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2021 | 4874 | 0.120 |
Why?
| | Microsatellite Instability | 2 | 2024 | 37 | 0.110 |
Why?
| | Male | 6 | 2021 | 63043 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2329 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2023 | 14471 | 0.070 |
Why?
| | Universities | 1 | 2009 | 399 | 0.070 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2025 | 15 | 0.060 |
Why?
| | Female | 5 | 2021 | 68266 | 0.060 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2024 | 33 | 0.060 |
Why?
| | Uterine Neoplasms | 1 | 2025 | 102 | 0.050 |
Why?
| | United States | 3 | 2021 | 13840 | 0.050 |
Why?
| | DNA Replication | 1 | 2024 | 225 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 59 | 0.050 |
Why?
| | Risk Assessment | 2 | 2024 | 3232 | 0.050 |
Why?
| | Microsatellite Repeats | 1 | 2022 | 161 | 0.050 |
Why?
| | Cause of Death | 1 | 2023 | 392 | 0.050 |
Why?
| | Kidney Diseases, Cystic | 1 | 2021 | 20 | 0.040 |
Why?
| | Pneumothorax | 1 | 2021 | 38 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7069 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 336 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 485 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2021 | 309 | 0.040 |
Why?
| | Protein Domains | 1 | 2021 | 252 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2020 | 199 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5045 | 0.040 |
Why?
| | Penetrance | 1 | 2018 | 27 | 0.040 |
Why?
| | Inheritance Patterns | 1 | 2018 | 46 | 0.040 |
Why?
| | Population Surveillance | 1 | 2021 | 435 | 0.040 |
Why?
| | Societies | 1 | 2017 | 36 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2018 | 68 | 0.040 |
Why?
| | Adult | 3 | 2021 | 35299 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 715 | 0.040 |
Why?
| | Counseling | 1 | 2020 | 384 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 1871 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 12349 | 0.030 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 190 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 222 | 0.030 |
Why?
| | Global Health | 1 | 2018 | 330 | 0.030 |
Why?
| | Neuroimaging | 1 | 2017 | 279 | 0.030 |
Why?
| | Disease Management | 1 | 2018 | 584 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 489 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 606 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1830 | 0.030 |
Why?
| | Parents | 1 | 2020 | 1307 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2553 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2517 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1614 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1146 | 0.020 |
Why?
| | Pediatrics | 1 | 2017 | 1050 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1635 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3387 | 0.020 |
Why?
|
|
Schneider's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|